welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy

key information

study id #: NCT02251600

condition: Duchenne Muscular Dystrophy

status: completed


Study to characterize the single-state and steady-state dosing of oral deflazacort in pediatric and adolescents subjects.

intervention: Deflazacort

mechanism of action: Glucocorticoid to delay decline in muscle strength

results: https://clinicaltrials.gov/ct2/show/results/NCT02251600

last updated: November 22, 2018